CM
RNAM

Caption Management’s Avidity Biosciences RNAM Stock Holding History

Caption Management’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-260,800
Closed -$18.8M – 1991
2025
Q4 		$18.8M Sell
260,800
-5,500
-2% -$355K 0.13% 185
2025
Q3 		$11.6M Buy
266,300
+104,300
+64% +$4.22M 0.09% 237
2025
Q2 		$4.6M Buy
162,000
+95,700
+144% +$2.85M 0.05% 428
2025
Q1 		$1.96M Sell
66,300
-23,700
-26% -$738K 0.02% 686
2024
Q4 		$2.62M Buy
+90,000
New +$3.76M 0.02% 603

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

Caption Management's RNAM Position: Q4 2025 in Review

Caption Management sold out of Avidity Biosciences (RNAM) in Q4 2025, closing a stake of 12,138 shares — an estimated $784K sold.

Caption Management first reported a position in RNAM in Q4 2024 and held it in 2 quarters. The position peaked at $896K in Q4 2024. 343 funds tracked by Wall St. Rank hold RNAM as of Q4 2025.

  • Caption Management reported no remaining Avidity Biosciences position as of Q4 2025 after selling out during the quarter.
  • Caption Management sold 12,138 Avidity Biosciences shares in Q4 2025, an estimated $784K.
  • Caption Management first reported a position in Avidity Biosciences in Q4 2024 and held it in 2 quarters.
  • Caption Management's Avidity Biosciences position peaked at $896K in Q4 2024.
  • 343 funds tracked by Wall St. Rank held Avidity Biosciences as of Q4 2025.

Based on Caption Management's 13F filing for Q4 2025, filed 17 Feb 2026.